#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	6730	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2137	306.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1358	1358	C	467	C,G	375,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15226	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3447	431.9	0	.	n	.	0	T695C	SNP	695	695	T	986	986	C	580	C	517	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15226	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3447	431.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1628	1628	A	412	A	380	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15226	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3447	431.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2262	2262	C	411	C	351	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15226	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3447	431.9	1	SNP	n	A2045G	1	A2045G	SNP	2045	2045	A	2336	2336	G	448	G	388	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15226	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3447	431.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2888	2888	C	448	C	365	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	140	folP	852	852	100.0	folP.l6.c4.ctg.1	1225	10.8	1	SNP	p	R228S	1	.	.	682	684	AGC	875	877	AGC	12;12;11	A;G;C	10;10;9	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	1	958	gyrA	2751	2174	99.82	gyrA.l6.c4.ctg.1	2174	32.4	1	SNP	p	S91F	0	.	.	271	273	TCC	122	124	TCC	18;17;17	T;C;C	17;16;16	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	1	958	gyrA	2751	2174	99.82	gyrA.l6.c4.ctg.1	2174	32.4	1	SNP	p	D95G	0	.	.	283	285	GAC	134	136	GAC	19;19;18	G;A;C	18;18;17	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	1	958	gyrA	2751	2174	99.82	gyrA.l6.c4.ctg.1	2174	32.4	1	SNP	p	D95N	0	.	.	283	285	GAC	134	136	GAC	19;19;18	G;A;C	18;18;17	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	1	958	gyrA	2751	423	100.0	gyrA.l6.c4.ctg.2	649	27.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	1	958	gyrA	2751	139	100.0	gyrA.l6.c4.ctg.3	343	16.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	392	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1311	28.7	1	SNP	p	G45D	1	.	.	133	135	GAC	405	407	GAC	17;19;19	G;A;C	15;17;17	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	272	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	505	52.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	1	1	512	534	parC	2298	1203	96.43	parC.l15.c17.ctg.1	1203	24.2	0	.	p	.	0	V148M	NONSYN	442	444	GTG	143	145	ATG	6;6;6	A;T;G	3;3;3	.	.
parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	1	1	512	534	parC	2298	1203	96.43	parC.l15.c17.ctg.1	1203	24.2	0	.	p	.	0	Q298R	NONSYN	892	894	CAG	593	595	CGG	12;12;13	C;G;G	11;11;12	.	.
parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	1	1	512	534	parC	2298	1203	96.43	parC.l15.c17.ctg.1	1203	24.2	0	.	p	.	0	T382V	NONSYN	1144	1146	ACC	845	847	GTC	50;53;52	G;T;C	40;41;41	.	.
parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	1	1	512	534	parC	2298	1203	96.43	parC.l15.c17.ctg.1	1203	24.2	0	.	p	.	0	T428A	NONSYN	1282	1284	ACC	983	985	GCC	39;39;39	G;C;C	33;33;33	.	.
parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	1	1	512	534	parC	2298	1203	96.43	parC.l15.c17.ctg.1	1203	24.2	0	.	p	.	0	A433V	NONSYN	1297	1299	GCG	998	1000	GTG	35;32;34	G;T;G	30;27;31	.	.
parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	1	1	512	534	parC	2298	1203	96.43	parC.l15.c17.ctg.1	1203	24.2	0	.	p	.	0	V489I	NONSYN	1465	1467	GTC	1166	1168	ATC	25;25;24	A;T;C	22;22;21	.	.
parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	1	1	512	534	parC	2298	178	97.75	parC.l15.c17.ctg.2	362	29.5	0	.	p	.	0	P6S	NONSYN	16	18	CCA	198	200	TCC	68;69;69	T;C;C	48;48;49	.	.
parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	1	1	512	534	parC	2298	607	95.22	parC.l15.c17.ctg.3	658	10.8	0	.	p	.	0	T519A	NONSYN	1555	1557	ACC	78	80	GCC	3;4;4	G;C;C	3;4;4	.	.
parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	1	1	512	534	parC	2298	607	95.22	parC.l15.c17.ctg.3	658	10.8	0	.	p	.	0	I564V	NONSYN	1690	1692	ATT	213	215	GTT	17;17;17	G;T;T	14;14;14	.	.
parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	1	1	512	534	parC	2298	607	95.22	parC.l15.c17.ctg.3	658	10.8	0	.	p	.	0	T578S	NONSYN	1732	1734	ACC	255	257	TCG	7;7;7	T;C;G	6;5;5	.	.
parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	1	1	512	534	parC	2298	607	95.22	parC.l15.c17.ctg.3	658	10.8	0	.	p	.	0	L579I	NONSYN	1735	1737	CTT	258	260	ATC	8;8;8	A;T;C	6;7;7	.	.
parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	parC.Neisseria_meningitidis_serogroup_A_Z2491_v1_01724	1	1	512	534	parC	2298	607	95.22	parC.l15.c17.ctg.3	658	10.8	0	.	p	.	0	N677S	NONSYN	2029	2031	AAT	552	554	AGT	16;16;16	A;G;T	12;12;12	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	556	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2332	22.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1466	1468	GGC	19;19;19	G;G;C	16;16;16	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	1463	100.0	penA.l6.c4.ctg.1	1797	45.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1263	1265	GCA	36;36;36	G;C;A	28;28;27	penA.56.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	1463	100.0	penA.l6.c4.ctg.1	1797	45.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1266	1268	ATC	37;37;37	A;T;C	29;29;29	penA.56.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	1463	100.0	penA.l6.c4.ctg.1	1797	45.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1278	1280	GTG	40;41;40	G;T;G	31;32;31	penA.56.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	1463	100.0	penA.l6.c4.ctg.1	1797	45.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1278	1280	GTG	40;41;40	G;T;G	31;32;31	penA.56.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	1463	100.0	penA.l6.c4.ctg.1	1797	45.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1782	1784	ACC	4;4;2	A;C;C	4;4;2	penA.56.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	250	93.63	penA.l6.c4.ctg.2	464	14.0	0	.	p	.	0	P542H	NONSYN	1624	1626	CCC	155	157	CAC	23;23;23	C;A;C	18;18;17	.	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	250	93.63	penA.l6.c4.ctg.2	464	14.0	0	.	p	.	0	G548V	NONSYN	1642	1644	GGA	173	175	GTA	18;18;18	G;T;A	15;15;14	.	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	250	93.63	penA.l6.c4.ctg.2	464	14.0	0	.	p	.	0	G550A	NONSYN	1648	1650	GGG	179	181	GCA	19;18;18	G;C;A	15;15;16	.	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	250	93.63	penA.l6.c4.ctg.2	464	14.0	0	.	p	.	0	G552P	NONSYN	1654	1656	GGG	185	187	CCG	14;13;13	C;C;G	12;11;11	.	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	250	93.63	penA.l6.c4.ctg.2	464	14.0	0	.	p	.	0	P554F	NONSYN	1660	1662	CCC	191	193	TTC	14;15;16	T;T;C	12;14;15	.	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	250	93.63	penA.l6.c4.ctg.2	464	14.0	0	.	p	.	0	G559fs	FSHIFT	1675	1675	G	206	206	G	18	G	18	.	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	250	93.63	penA.l6.c4.ctg.2	464	14.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	158	160	GGC	22;22;22	G;G;C	18;18;17	penA.56.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.56.001	penA.56.001	1	1	513	902	penA	1719	250	93.63	penA.l6.c4.ctg.2	464	14.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	167	169	GGC	22;22;21	G;G;C	19;18;18	penA.56.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	0	1828	ponA	2397	1154	100.0	ponA.l15.c30.ctg.1	1625	59.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	18	20	CTG	11;11;11	C;T;G	8;8;8	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	0	1828	ponA	2397	985	100.0	ponA.l15.c30.ctg.2	1228	64.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	513	612	porA	1146	311	99.68	porA.l15.c4.ctg.1	642	14.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	578	578	C	3	C	3	.	.
porA.NCCP11945	porA.NCCP11945	1	0	513	612	porA	1146	804	99.88	porA.l15.c4.ctg.2	1145	43.8	0	.	p	.	0	D129G	NONSYN	385	387	GAC	43	45	GGC	6;6;6	G;G;C	6;6;6	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	A26V	NONSYN	76	78	GCC	296	298	GTC	39;38;38	G;T;C	35;34;34	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	E48G	NONSYN	142	144	GAA	362	364	GGA	39;39;39	G;G;A	27;27;27	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	T87A	NONSYN	259	261	ACT	479	481	GCT	9;9;9	G;C;T	9;9;9	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	T89S	NONSYN	265	267	ACC	485	487	AGC	9;9;9	A;G;C	9;9;8	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	.	MULTIPLE	358	359	AA	577	578	CG	11;11	C;G	8;8	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	.	MULTIPLE	361	362	GA	580	582	CAG	11;11;11	C;A;G	8;8;8	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	N122K	NONSYN	364	366	AAC	584	586	AAA	12;13;14	A;A;A	8;8;9	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	A125T	NONSYN	373	375	GCT	593	595	ACT	16;15;15	A;C;T	11;12;12	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	N134S	NONSYN	400	402	AAT	620	622	AGT	13;13;13	A;G;T	11;11;11	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	E137K	NONSYN	409	411	GAA	629	631	AAA	13;12;13	A;A;A	12;11;12	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	K143E	NONSYN	427	429	AAA	647	649	GAA	15;18;18	G;A;A	13;16;16	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	V151A	NONSYN	451	453	GTA	671	673	GCA	25;25;25	G;C;A	24;24;24	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	779	781	CAA	110;110;109	C;A;A	84;84;83	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	N189S	NONSYN	565	567	AAC	785	787	AGC	111;111;111	A;G;C	83;82;83	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	M209I	NONSYN	625	627	ATG	845	847	ATC	88;87;86	A;T;C	76;76;75	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	0	.	p	.	0	E210fs	FSHIFT	628	628	G	848	848	G	87	G	75	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	1	SNP	p	G120K	1	.	.	358	360	AAG	577	579	CGG	11;11;11	C;G;G	8;8;8	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	1	SNP	p	D121N	0	.	.	361	363	GAC	580	583	CGC	11;11;12	C;G;C	8;8;8	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	692	porB1b	1041	1041	96.56	porB1b.l15.c4.ctg.1	1552	43.4	1	SNP	p	A121D	1	.	.	361	363	GAC	580	583	CGC	11;11;12	C;G;C	8;8;8	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2566	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4814	52.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1982	1984	AAT	21;21;21	A;A;T	20;20;20	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	260	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	927	27.3	1	SNP	p	V57M	1	.	.	169	171	ATG	434	436	ATG	65;66;65	A;T;G	60;61;60	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
